The NIMH MATRICS Initiative: Development of a Consensus Cognitive Battery
Progress in Neurotherapeutics and Neuropsychopharmacology · 2007
DOI: 10.1017/s1748232106000127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress in Neurotherapeutics and Neuropsychopharmacology, 2007. Verfasst von Robert S. Kern und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
A key obstacle to the development of new drugs to treat the cognitive deficits of schizophrenia was the absence of a standard by which to measure their efficacy. Before granting approval for any new drug for this condition, the US Food and Drug Administration wanted a standard cognitive endpoint based on a broad consensus-based method. To address this obstacle, the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) intiative oversaw a process to develop a consensus neurocognitive battery. Its development included a ten-step process that is described in this article.
Zitieren
APA
Kern, R. S., Green, M. F., & Marder, S. R. (2007). The NIMH MATRICS Initiative: Development of a Consensus Cognitive Battery. Progress in Neurotherapeutics and Neuropsychopharmacology. https://doi.org/10.1017/s1748232106000127
Vancouver
Kern RS, Green MF, Marder SR. The NIMH MATRICS Initiative: Development of a Consensus Cognitive Battery. Progress in Neurotherapeutics and Neuropsychopharmacology. 2007. doi:10.1017/s1748232106000127
BibTeX
@article{Kern2007,
author = {Kern, Robert S. and Green, Michael F. and Marder, Stephen R.},
title = {The NIMH MATRICS Initiative: Development of a Consensus Cognitive Battery},
journal = {Progress in Neurotherapeutics and Neuropsychopharmacology},
year = {2007},
doi = {10.1017/s1748232106000127}
}
EUVIMED